BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9713312)

  • 1. The guanine triphosphatase (GTPase) activating protein (GAP)-related domain of the neurofibromatosis type 1 gene is not mutated in neural crest-derived sporadic tumours.
    Murgia A; Anglani F; Vinanzi C; Polli R; Basso G; Perilongo G; Giangaspero F; Zacchello F
    Eur J Cancer; 1998 Mar; 34(4):577-9. PubMed ID: 9713312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
    Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
    Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
    Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
    Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
    Martin GA; Viskochil D; Bollag G; McCabe PC; Crosier WJ; Haubruck H; Conroy L; Clark R; O'Connell P; Cawthon RM
    Cell; 1990 Nov; 63(4):843-9. PubMed ID: 2121370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
    Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
    Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.
    Morcos P; Thapar N; Tusneem N; Stacey D; Tamanoi F
    Mol Cell Biol; 1996 May; 16(5):2496-503. PubMed ID: 8628317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
    Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
    Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
    Upadhyaya M; Osborn MJ; Maynard J; Kim MR; Tamanoi F; Cooper DN
    Hum Genet; 1997 Jan; 99(1):88-92. PubMed ID: 9003501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
    Scheurlen WG; Senf L
    Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
    Griesser J; Kaufmann D; Eisenbarth I; Bäuerle C; Krone W
    Biol Chem Hoppe Seyler; 1995 Feb; 376(2):91-101. PubMed ID: 7794530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.
    Xu H; Gutmann DH
    Brain Res; 1997 Jun; 759(1):149-52. PubMed ID: 9219873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of cellular activities by GTPase-activating protein and NF1.
    al-Alawi N; Xu G; White R; Clark R; McCormick F; Feramisco JR
    Mol Cell Biol; 1993 Apr; 13(4):2497-503. PubMed ID: 8455625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the neurofibromatosis type 1 protein product.
    DeClue JE; Cohen BD; Lowy DR
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetics of neurofibromatosis type 1].
    Suzuki H; Takahashi K; Shibahara S
    Nihon Rinsho; 1993 Sep; 51(9):2457-61. PubMed ID: 8411728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
    Nur-E-Kamal MS; Varga M; Maruta H
    J Biol Chem; 1993 Oct; 268(30):22331-7. PubMed ID: 8226742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
    Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
    Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of neurofibromin in the soft tissue tumours obtained from patients with neurofibromatosis type I.
    Takahashi K; Suzuki H; Hatori M; Abe Y; Kokubun S; Sakurai M; Shibahara S
    Clin Sci (Lond); 1995 May; 88(5):581-5. PubMed ID: 7614817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the GAP-related domain from neurofibromin and its implications.
    Scheffzek K; Ahmadian MR; Wiesmüller L; Kabsch W; Stege P; Schmitz F; Wittinghofer A
    EMBO J; 1998 Aug; 17(15):4313-27. PubMed ID: 9687500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
    Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
    J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.